# Medical Oncology (genitourinary) Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Pablo Neruda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML051-SYN-TD
- Date: 1971-06-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marisol Fairweather-Diaz, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Étienne Okonkwo-Lund, MD, Medical Oncology (genitourinary)
- Urgency: Urgent, within two weeks

## Referral question

Man of 66 with four months of urinary symptoms and six weeks of right hip and low back pain, a hard nodular prostate, PSA 46.8 ng/mL and a raised alkaline phosphatase: suspected metastatic prostate cancer. Please confirm the diagnosis and extent and advise on treatment, including bone health and genetic testing. **S**

## Questions for the consultant

1. Do the results confirm prostate cancer, and what is the extent and volume of disease?
2. Which systemic treatment do you recommend, and is docetaxel indicated?
3. Is radiotherapy to the prostate indicated?
4. How should bone health and the bone metastases be managed, including the need for a bone-protective drug and at what dose?
5. Should he have germline and tumor genetic testing?
6. How will the treatment interact with his amlodipine, and which monitoring should primary care carry out?

## Pertinent history

Poet and diplomat, posted abroad; Spanish is his first language and a professional interpreter is used. Four months of frequency, weak stream and nocturia three times (IPSS 17); six weeks of aching right buttock and hip pain and low back pain, worse at night, pain 6 of 10. No leg weakness, numbness, or change in bladder or bowel control. Digital rectal examination: hard, nodular right lobe with loss of the right lateral border. Hypertension for five years on amlodipine 5 mg; blood pressure 146/88 mm Hg today. Never smoker. Laboratory tests today: PSA 46.8 ng/mL, testosterone 468 ng/dL, hemoglobin 13.6 g/dL, creatinine 0.96 mg/dL, calcium 9.6 mg/dL, alkaline phosphatase 168 U/L, LDH 208 U/L, hemoglobin A1c 5.9 percent, LDL 140 mg/dL, 25-hydroxyvitamin D 22 ng/mL. PHQ-9 score 6. MRI of the prostate, a targeted biopsy at the urology practice, CT of the chest, abdomen and pelvis, a bone scan and PSMA PET/CT are being arranged before your visit. Acetaminophen started for pain. **S**

- Pablo Neruda was born on 12 July 1904 in the town of Parral in Chile. His father was a railway employee, and his mother, a teacher, died shortly after his birth; he spent his childhood and youth in Temuco. **D**
- He used the pen name Pablo Neruda from 1920. The Nobel Prize biography gives his real name as Neftalí Ricardo Reyes Basoalto; the Library of the National Congress of Chile gives his birth name as Ricardo Eliecer Neftalí Reyes Basoalto and records that a court judgment of 28 December 1946 changed it to Pablo Neruda. **D**
- Between 1927 and 1935 he held a series of honorary consulships in Burma, Ceylon, Java, Singapore, Buenos Aires, Barcelona and Madrid; in 1945 he was elected a senator of the Republic and joined the Communist Party of Chile. **D**
- After the 1970 presidential election he was named Chile's ambassador to France; the Senate approved the appointment on 21 January 1971 and he presented his credentials at the end of that month. He resigned the post in 1972 and returned to Chile in November 1972. **D**

9 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: PSA: 46.8 ng/mL (high); Total testosterone: 468 ng/dL; Hemoglobin: 13.6 g/dL; White cell count: 6.4 10*3/uL; Platelets: 248 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Glucose: 104 mg/dL (high); Creatinine: 0.96 mg/dL; eGFR (CKD-EPI 1966): 87 mL/min/1.73 m²; Calcium: 9.6 mg/dL; ALT: 22 U/L; AST: 24 U/L; Alkaline phosphatase: 168 U/L (high); Albumin: 4.1 g/dL; LDH: 208 U/L; Hemoglobin A1c: 5.9% (high); Total cholesterol: 214 mg/dL (high); HDL cholesterol: 46 mg/dL; LDL cholesterol: 140 mg/dL (high); Triglycerides: 140 mg/dL; 25-hydroxyvitamin D: 22 ng/mL (low); PHQ-9: 6; IPSS total (0 to 35): 17; Pain, 0 to 10: 6. All results are synthetic.

BP 146/88 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 92.4 kg; BMI 29.2 kg/m². All vital signs are synthetic.

## Current medications

- Amlodipine 5 mg oral tablet, one tablet daily **S**
- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) up to three times daily as needed for bone pain **S**

## Plan so far

- Diagnosis and staging: multiparametric MRI of the prostate, an MRI-targeted transperineal biopsy at the urology practice, CT of the chest, abdomen and pelvis, a bone scan, and PSMA PET/CT. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Advanced Prostate Cancer: AUA/SUO Guideline, first published 2020 and amended 2023 and 2026 (2026); CMID: Clinical Monitoring Intelligence Database, prostate cancer and hypertension monographs (2026) **S**
- Bone pain: acetaminophen 1000 mg up to three times a day; spinal cord compression warning signs explained in Spanish, with same-day assessment for new leg weakness or numbness, or loss of bladder or bowel control. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026) **S**
- Care in Spanish, his first language: a professional medical interpreter for every major discussion, written plans in Spanish, appointments placed around his morning writing and his official duties. Guideline: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026) **S**
